We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Changes in Brain White Matter Could Portend Dementia

By HospiMedica International staff writers
Posted on 08 Jul 2010
New insights into physical changes in the brain offer the possibility of targeted early diagnosis and prevention of vascular dementia.

Researchers at the University Hospital de Santa Maria (Lisbon, Portugal) followed 639 subjects without dementia (aged 65 to 84) and investigated the extent and location of changes in the white matter of their brain during a period of three years; 90 of the subjects developed various forms of dementia during this period, primarily vascular dementia, Alzheimer's dementia, and a mixed form of the two. More...
The researchers were able to demonstrate that periventricular leukoaraiosis-- specific symmetrical changes which can be detected with high resolution magnetic resonance imaging (MRI) in the white matter--was an independent indicator for the development of dementia, and should not be considered just as a symptom of old age. The results of the study were presented at the annual meeting of the European Neurological Society (ENS), held during June 2010 in Berlin (Germany).

"This finding deepens our understanding of vascular dementia. We can hope to build on this so that we are able in future to earlier detect and better prevent this form of mental decline which is so agonizing to those affected and their families,” said lead author and study presenter Bruno Miranda, M.D. "Further studies will demonstrate whether we can help people with leukoaraiosis in deep brain regions by aggressive treatment of the underlying diseases, such as high blood pressure or diabetes, to a better prognosis and prevent or at least delay the outbreak of vascular dementia.”

Vascular dementia develops (in contrast to Alzheimer's dementia) through pathological changes to blood vessels as a result of high blood pressure, diabetes, high blood fat levels, or smoking. While Alzheimer's disease primarily affects memory, vascular dementia causes abnormalities of the so-called executive brain functions, which are reliant on the connectivity of many regions of the brain, such as the ability to judge the cost/benefit relation of an offer and to make appropriate decisions.

Related Links:

University Hospital de Santa Maria



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.